↓ Skip to main content

Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa

Overview of attention for article published in Cost Effectiveness and Resource Allocation, September 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
4 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
102 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa
Published in
Cost Effectiveness and Resource Allocation, September 2014
DOI 10.1186/1478-7547-12-20
Pubmed ID
Authors

Liezl Channing, Edina Sinanovic

Abstract

Tuberculosis remains the leading cause of death in South Africa. A number of potential new TB vaccine candidates have been identified and are currently in clinical trials. One such candidate is MVA85A. This study aimed to estimate the cost-effectiveness of adding the MVA85A vaccine as a booster to the BCG vaccine in children from the perspective of the South African government.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Canada 1 <1%
South Africa 1 <1%
Unknown 99 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 14%
Researcher 13 13%
Student > Master 13 13%
Student > Ph. D. Student 6 6%
Student > Postgraduate 5 5%
Other 9 9%
Unknown 42 41%
Readers by discipline Count As %
Medicine and Dentistry 15 15%
Pharmacology, Toxicology and Pharmaceutical Science 12 12%
Social Sciences 6 6%
Economics, Econometrics and Finance 5 5%
Agricultural and Biological Sciences 4 4%
Other 13 13%
Unknown 47 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2014.
All research outputs
#15,740,207
of 25,374,647 outputs
Outputs from Cost Effectiveness and Resource Allocation
#327
of 533 outputs
Outputs of similar age
#128,697
of 246,376 outputs
Outputs of similar age from Cost Effectiveness and Resource Allocation
#3
of 4 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 533 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 246,376 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.